IRE ELIT RADIOPHARMA
Live / Registered — Registered (as of 25 May 2021)
What this means for you
Registered since 25 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88828607
- Registration number
- 6359190
- Mark type
- Design + words
- Filed
- 10 Mar 2020
- Published for opposition
- 09 Mar 2021
- Registered
- 25 May 2021
- Attorney of record
- Thomas J. Mango
Goods and services
- Class 001 — Chemicals: Radiochemical products for scientific purposes; radioactive elements for scientific purposes; radioactive elements for industrial purposes
- Class 005 — Pharmaceuticals: Radiopharmaceutical products, namely, diagnostic or therapy radiopharmaceutical preparations; radioactive substances and active pharmaceutical ingredients in the nature of isotopes for medical use
- Class 042 — Scientific and technological services: Scientific technological services, namely, radiological analysis and monitoring in the field of radioactivity to support medical applications; scientific research and development, namely, radiological monitoring and measurement to support medical applications; scientific and technological consultancy and surveys in the field of radioactivity to support medical applications
Owner
Prosecution history
- 25 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Mar 2021 — PUBLISHED FOR OPPOSITION
- 17 Feb 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jan 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jan 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jan 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jan 2021 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 21 Jan 2021 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 21 Jan 2021 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 21 Jan 2021 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 26 Oct 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 26 Oct 2020 — FINAL REFUSAL E-MAILED
- 26 Oct 2020 — FINAL REFUSAL WRITTEN